Advertisement
 
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

FDA Approves Arzerra for Chronic Lymphocytic Leukemia

April 18, 2014 12:03 pm | News | Comments

GlaxoSmithKline and Genmab announced that the FDA has approved a supplemental BLA for the use of Arzerra, a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukemia. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Breaking News: Cubist Recalls Cubicin Lot

April 18, 2014 2:02 pm | News | Comments

Cubist Pharmaceuticals Inc. announced it is voluntarily recalling one lot of Cubicin (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles. Read more...

TOPICS:

Top French Advisor Resigns Amid Drug Industry Scandal

April 18, 2014 1:06 pm | News | Comments

Aquilino Morelle, the French president's top adviser, resigned Friday following allegations of a past conflict of interest, striking a new blow to the already unpopular Francois Hollande, sought to distance himself from the new scandal. Read more...

TOPICS:

Washington University Launches Immunology Center

April 18, 2014 12:54 pm | by Michael Purdy | News | Comments

A new center at Washington University School of Medicine in St. Louis - The Center for Human Immunology and Immunotherapy Programs (CHiiPs)  -  will help scientists use the power of the immune system to fight infections and cancers. Read more...

TOPICS:
Advertisement

Anti-Seizure Drug Could Reduce Alcohol Consumption

April 18, 2014 10:34 am | News | Comments

Researchers have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption in an experimental model. The findings may lead to more effective treatments for alcoholism. Read more...               

TOPICS:

Actavis to Acquire New Products from Akorn

April 18, 2014 10:19 am | News | Comments

Actavis plc announced that it has entered into agreements with Akorn Inc. and Hi-Tech Pharmacal Co. Inc. to purchase four currently marketed products and one product under development for cash consideration. Read more...         

TOPICS:

Multi-Target TB Drug May Treat Other Diseases, Evade Resistance

April 18, 2014 9:53 am | News | Comments

A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a new study. Read more...     

TOPICS:

Canada is First to Approve GSK's New COPD Drug

April 18, 2014 9:43 am | News | Comments

GlaxoSmithKline announced that Incruse Ellipta has received world-first market authorization in Canada for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD. Read more...       

TOPICS:

Canada is First to Approve GSK's New COPD Drug

April 18, 2014 9:43 am | News | Comments

GlaxoSmithKline announced that Incruse Ellipta has received world-first market authorization in Canada for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD. Read more...       

TOPICS:
Advertisement

Servier, Lab Founder in Drug Scandal, Dies at 92

April 18, 2014 9:17 am | News | Comments

Jacques Servier, the founder of France's second-largest pharmaceutical group who became ensnared in a scandal over a diabetes drug widely used for weight loss, has died. Read more...                   

TOPICS:

FDA OKs Merck Tablet to Reduce Ragweed Allergies

April 18, 2014 9:00 am | News | Comments

U.S. regulators have again approved Merck & Co.'s Ragwitek tablets, which dissolve quickly under the tongue, for gradually reducing seasonal allergies, this time for ragweed pollen. Read more...             

TOPICS:

Productive, Hands-Free Evaporation

April 17, 2014 3:39 pm | Product Releases | Comments

For laboratories tired of having to constantly attend to multiple rotary evaporators, the Rocket Evaporator from Genevac sets the benchmark for productivity and ease-of-use. Read more...

TOPICS:

NIH Awards Scripps $2M to Design a Better Diabetes Drug Model

April 17, 2014 1:21 pm | News | Comments

Scientists from the Florida campus of TSRI have been awarded $2.1 million from the NIH to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and CHF. Read more...

TOPICS:

Finding Suggests New Possibilities for Oncology and Virology

April 17, 2014 1:06 pm | News | Comments

Scientists at Washington University School of Medicine in St. Louis have uncovered a new way the immune system may fight cancers and viral infections, which could aid efforts to use immune cells to treat illness. Read more...     

TOPICS:

Sanguine, Mayo Clinic Agreement Furthers Personalized Medicine

April 17, 2014 12:40 pm | News | Comments

Sanguine announced an agreement with Mayo Clinic Bioservices, under which Mayo Clinic Bioservices will process, store and ship biospecimens that Sanguine has collected. Read more...                   

TOPICS:

New Gene Technology Has Therapeutic Implications

April 17, 2014 12:16 pm | News | Comments

For thousands of years humans have been tinkering with plant genetics, even when they didn’t realize that is what they were doing, in an effort to make stronger, healthier crops that endured climates better, and produced more. Read more...   

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading